E2V.L Regulatory News (E2V)

28 Apr 2009 07:00



28th April 2009 

e2v technologies plc

e2v secures radiotherapy supply and support contract 

e2v technologies, a developer and manufacturer of specialised components and sub-systems, announces a multi-year supply and support contract with TomoTherapy Inc, an existing customer based in Wisconsin, USA, valued at £7.4m. 

Under this sole supplier arrangement, e2v will supply magnetrons from its electron device and sub-systems division for use in radiotherapy cancer treatment systems. The contract includes the initial supply and on-going spares requirements for these systems.

The new contract structure builds on e2v's long standing relationship with its customer, is effective 1st May and covers a 3 year period.

e2v's products generate and deliver the microwave power required from the linear accelerator within the radiotherapy cancer treatment system to produce the X-rays used in both the imaging and radiation treatment of tumours. 

For further information:

NOTES FOR EDITORS

e2v 

e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for medical and science, aerospace and defence, and commercial and industrial markets.

e2v has 4 major product groups:

High performance electron devices and subsystems for applications including defence electronic countermeasures, radiotherapy cancer treatment, and radar systems

Advanced Imaging sensors and cameras for applications including industrial process control, dental X-ray systems, space science and life sciences

Specialist semiconductors, including logic, memory and microprocessors for high reliability mission-critical programs in avionics, defence and telecommunications, sensor data acquisition, and high speed data conversion

A range of professional sensing products for applications including fire, rescue and security thermal imaging, X-ray spectroscopy, and military surveillance, targeting and guidance

For the year ended 31 March 2008, e2v achieved sales of £205m and is listed on the London Stock Exchange. In October 2008 e2v acquired QP semiconductor, a leading US-based designer and supplier of specialty semiconductor components used in military and aerospace applications, establishing e2v's first US manufacturing base. 

The Company is headquartered in the United Kingdom and has approximately 1800 employees in six production facilities across Europe and North America. e2v also operates a global network of sales and technical support offices, supported by local distributors and resellers.

Further information is available from www.e2v.com